111 related articles for article (PubMed ID: 32352682)
1. The Association Between Cholecystectomy, Metabolic Syndrome, and Nonalcoholic Fatty Liver Disease: A Population-Based Study.
Latenstein CSS; Alferink LJM; Darwish Murad S; Drenth JPH; van Laarhoven CJHM; de Reuver PR
Clin Transl Gastroenterol; 2020 Apr; 11(4):e00170. PubMed ID: 32352682
[TBL] [Abstract][Full Text] [Related]
2. Self-reported snoring is associated with nonalcoholic fatty liver disease.
Wang H; Gao Q; He S; Bao Y; Sun H; Meng L; Liang J; Sun C; Chen S; Cao L; Huang W; Zhang Y; Huang J; Wu S; Wang T
Sci Rep; 2020 Jun; 10(1):9267. PubMed ID: 32518245
[TBL] [Abstract][Full Text] [Related]
3. Nonalcoholic fatty liver disease (NAFLD) detection and deep learning in a Chinese community-based population.
Yang Y; Liu J; Sun C; Shi Y; Hsing JC; Kamya A; Keller CA; Antil N; Rubin D; Wang H; Ying H; Zhao X; Wu YH; Nguyen M; Lu Y; Yang F; Huang P; Hsing AW; Wu J; Zhu S
Eur Radiol; 2023 Aug; 33(8):5894-5906. PubMed ID: 36892645
[TBL] [Abstract][Full Text] [Related]
4. Ankle systolic pressure index in non-diabetic non-alcoholic fatty liver disease: A case-control study.
Taharboucht S; Guermaz R; Brouri M; Bengherbia L; Chibane A
J Med Vasc; 2023; 48(5-6):154-162. PubMed ID: 38035921
[TBL] [Abstract][Full Text] [Related]
5. Association between nonalcoholic fatty liver disease and gallstone risk in nonobese and lean individuals.
Kim NH; Kang JH; Kim HJ
Eur J Gastroenterol Hepatol; 2024 Jul; 36(7):945-951. PubMed ID: 38652507
[TBL] [Abstract][Full Text] [Related]
6. The grade of nonalcoholic fatty liver disease is an independent risk factor for gallstone disease: An observational Study.
Kim YK; Kwon OS; Her KH
Medicine (Baltimore); 2019 Jul; 98(27):e16018. PubMed ID: 31277096
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of non-alcoholic fatty liver in the general Dutch population and in groups at increased risk.
Alblas G; Lamb HJ; Rosendaal FR; van Hoek B; Coenraad MJ; de Mutsert R
Nutr Metab Cardiovasc Dis; 2023 Dec; 33(12):2497-2507. PubMed ID: 37798233
[TBL] [Abstract][Full Text] [Related]
8. Preliminary Study on Risk Factors for Morbidity of Nonalcoholic Fatty Liver Disease in High-Income Male Population.
Han L; Zhang Y; Yue C; Huang Y; Wu Y; Chen J
J Healthc Eng; 2022; 2022():9331284. PubMed ID: 35251583
[TBL] [Abstract][Full Text] [Related]
9. The association between platelet-related parameters and nonalcoholic fatty liver disease in a metabolically healthy nonobese population.
Choe EK; Kang HY
Sci Rep; 2024 Mar; 14(1):6118. PubMed ID: 38480828
[TBL] [Abstract][Full Text] [Related]
10. Increased prevalence of metabolic syndrome and non-alcoholic fatty liver disease in children with atopic dermatitis: A case-control study from northern India.
Reddy P; Mahajan R; Mehta H; De D; Bhatia A; Kumar R; Handa S
Pediatr Dermatol; 2024; 41(3):421-427. PubMed ID: 38165012
[TBL] [Abstract][Full Text] [Related]
11. Nonalcoholic Fatty Liver Disease in Japan Continue to Increase Even after the Launch of Specific Health Checkups.
Sato A; Oomori Y; Nakano R; Matsuura T
Intern Med; 2024 Mar; 63(6):763-771. PubMed ID: 37532550
[TBL] [Abstract][Full Text] [Related]
12. Harnessing Metabolic Indices as a Predictive Tool for Cardiovascular Disease in a Korean Population without Known Major Cardiovascular Event.
Kim HJ; Kim BS; Lee Y; Ahn SB; Kim DW; Shin JH
Diabetes Metab J; 2024 May; 48(3):449-462. PubMed ID: 38310879
[TBL] [Abstract][Full Text] [Related]
13. Sex-Specific Association between Sodium Intake Estimated by 24-Hour Urinary Sodium Excretion and Nonalcoholic Fatty Liver Disease: The Community-Based Prospective Cohort Study.
Lee J; Lee JY; Yang YJ
Nutrients; 2024 Feb; 16(4):. PubMed ID: 38398872
[TBL] [Abstract][Full Text] [Related]
14. Association of non-alcoholic fatty liver disease with gallstone disease in the United States hospitalized patient population.
Kichloo A; Solanki S; Haq KF; Dahiya D; Bailey B; Solanki D; Singh J; Albosta M; Wani F; Aljadah M; Shah H; Khan H; Jafri SM
World J Gastrointest Pathophysiol; 2021 Mar; 12(2):14-24. PubMed ID: 33815863
[TBL] [Abstract][Full Text] [Related]
15. Non-alcoholic fatty liver disease and metabolic syndrome in Brazilian middle-aged and older adults.
Karnikowski M; Córdova C; Oliveira RJ; Karnikowski MG; Nóbrega Ode T
Sao Paulo Med J; 2007 Nov; 125(6):333-7. PubMed ID: 18317603
[TBL] [Abstract][Full Text] [Related]
16. A Systematic Machine Learning Based Approach for the Diagnosis of Non-Alcoholic Fatty Liver Disease Risk and Progression.
Perveen S; Shahbaz M; Keshavjee K; Guergachi A
Sci Rep; 2018 Feb; 8(1):2112. PubMed ID: 29391513
[TBL] [Abstract][Full Text] [Related]
17. Copper-Fructose Interactions: A Novel Mechanism in the Pathogenesis of NAFLD.
Song M; Vos MB; McClain CJ
Nutrients; 2018 Nov; 10(11):. PubMed ID: 30469339
[TBL] [Abstract][Full Text] [Related]
18. Underlying nonalcoholic fatty liver disease is a significant factor for breast cancer recurrence after curative surgery.
Lee YS; Lee HS; Chang SW; Lee CU; Kim JS; Jung YK; Kim JH; Seo YS; Yim HJ; Lee CH; Woo SU; Seo JH; Yeon JE; Um SH; Byun KS
Medicine (Baltimore); 2019 Sep; 98(39):e17277. PubMed ID: 31574842
[TBL] [Abstract][Full Text] [Related]
19. HbA1c of 5.8% or higher as the most useful indicator for recommendation of ultrasonography to detect nonalcoholic fatty liver disease.
Tatsuta M; Ono M; Kimura S; Zuigyo K; Sato Y; Tomida A; Kobayashi M; Yoshikawa R; Murao S; Tani J; Morishita A; Kobara H; Himoto T; Maeta T; Mori Y; Kohi F; Masaki T
JGH Open; 2023 Dec; 7(12):990-997. PubMed ID: 38162856
[TBL] [Abstract][Full Text] [Related]
20. Non-alcoholic Fatty Liver Disease and Gallstones: A Systematic Review.
Slouha E; Biput SJ; Kuteyi A; Kalloo AE; Gorantla VR
Cureus; 2023 Sep; 15(9):e45027. PubMed ID: 37829934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
